1. Home
  2. PLRX vs VINP Comparison

PLRX vs VINP Comparison

Compare PLRX & VINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLRX
  • VINP
  • Stock Information
  • Founded
  • PLRX 2015
  • VINP 2009
  • Country
  • PLRX United States
  • VINP Brazil
  • Employees
  • PLRX N/A
  • VINP N/A
  • Industry
  • PLRX Biotechnology: Pharmaceutical Preparations
  • VINP Investment Managers
  • Sector
  • PLRX Health Care
  • VINP Finance
  • Exchange
  • PLRX Nasdaq
  • VINP Nasdaq
  • Market Cap
  • PLRX 682.2M
  • VINP 641.7M
  • IPO Year
  • PLRX 2020
  • VINP 2021
  • Fundamental
  • Price
  • PLRX $10.92
  • VINP $10.10
  • Analyst Decision
  • PLRX Strong Buy
  • VINP Strong Buy
  • Analyst Count
  • PLRX 7
  • VINP 2
  • Target Price
  • PLRX $40.50
  • VINP $13.50
  • AVG Volume (30 Days)
  • PLRX 454.1K
  • VINP 72.5K
  • Earning Date
  • PLRX 02-26-2025
  • VINP 02-05-2025
  • Dividend Yield
  • PLRX N/A
  • VINP 6.34%
  • EPS Growth
  • PLRX N/A
  • VINP N/A
  • EPS
  • PLRX N/A
  • VINP 0.60
  • Revenue
  • PLRX N/A
  • VINP $88,217,697.00
  • Revenue This Year
  • PLRX N/A
  • VINP $17.23
  • Revenue Next Year
  • PLRX N/A
  • VINP $51.06
  • P/E Ratio
  • PLRX N/A
  • VINP $16.88
  • Revenue Growth
  • PLRX N/A
  • VINP 9.03
  • 52 Week Low
  • PLRX $10.22
  • VINP $9.01
  • 52 Week High
  • PLRX $18.92
  • VINP $11.85
  • Technical
  • Relative Strength Index (RSI)
  • PLRX 36.45
  • VINP 55.39
  • Support Level
  • PLRX $10.68
  • VINP $9.61
  • Resistance Level
  • PLRX $11.40
  • VINP $10.25
  • Average True Range (ATR)
  • PLRX 0.71
  • VINP 0.24
  • MACD
  • PLRX -0.14
  • VINP 0.07
  • Stochastic Oscillator
  • PLRX 7.92
  • VINP 86.01

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

About VINP Vinci Partners Investments Ltd.

Vinci Partners Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Market; Liquid Strategies; Investment Products and solutions; Financial Advisory; and Retirement Services. The company's majority of its revenue comes from the Private Market segment which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.

Share on Social Networks: